Safety and Efficacy of NK510 to Treat NSCLC
Clinical trial NCT06097962 · RECRUITING
Trial details
- NCT number
- NCT06097962
- Sponsor
- Base Therapeutics (Shanghai) Co., Ltd.
- Status
- RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-01
- Primary completion
- 2026-07-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.